Proteome Sciences (LON:PRM) Posts Quarterly Earnings Results

Posted by on Sep 16th, 2026

Proteome Sciences (LON:PRM – Get Free Report) announced its earnings results on Wednesday. The company reported GBX (0.41) earnings per share (EPS) for the quarter, Digital Look Earnings reports. Proteome Sciences had a positive return on equity of 33.80% and a negative net margin of 81.50%.

Proteome Sciences Price Performance

Proteome Sciences stock traded up GBX 0.24 during trading hours on Wednesday, hitting GBX 1.69. 456,132 shares of the stock were exchanged, compared to its average volume of 374,427. The stock has a market capitalization of £5.93 million, a P/E ratio of -1.62 and a beta of 0.16. The business’s 50-day moving average is GBX 1.72 and its two-hundred day moving average is GBX 1.64. The company has a debt-to-equity ratio of -165.46, a quick ratio of 0.37 and a current ratio of 0.13. Proteome Sciences has a 12 month low of GBX 1.11 and a 12 month high of GBX 4.40.

About Proteome Sciences

(Get Free Report)

Proteome Sciences plc provides contract research services for the identification, validation, and application of protein biomarkers in the United States, the United Kingdom, European Union, and internationally. The company offers TMT LC-MS2, a standard method for analyzing cells and tissues when no phosphopeptide enrichment is required; TMT LC-MS3, a standard method for biomarker discovery in plasma and other samples where quantitative accuracy is a factor; SysQuant, provides an analysis of protein activity across regulatory and signaling pathways; and TMTcalibrator, analyzes where diseased or treated tissue can be analyzed in parallel with peripheral fluids.

Featured Articles

Earnings History for Proteome Sciences (LON:PRM)

Receive News & Ratings for Proteome Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Proteome Sciences and related companies with MarketBeat.com's FREE daily email newsletter.